Skip to main content
Caplight Logo









Ahead Therapeutics

Ahead Therapeutics

Private
BarcelonaHealthcare & Life Scienceshttps://aheadtherapeutics.com/

Last Round

Grant

Jan 29, 2026

Est. Valuation

$14.12M

Total Funding Raised

$6.81M

Company Overview

Ahead Therapeutics is a biotechnology company that develops antigen-specific immune tolerance-generating therapies for autoimmune diseases using its proprietary MiMi-ToP nanotechnology platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanomedicineimmune toleranceautoimmune therapyliposome drug deliveryantigen-specific therapybiotech startupdrug discoveryimmunotherapypreclinical biotechtolerogenicdrug developmentautoimmune diseasenext-gen pharmatargeted therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ahead Therapeutics Comparables

Compare Ahead Therapeutics with similar companies based on industry and business-model similarity.

Ahead Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anokion
85%
Topas Therapeutics
83%
Evoq Therapeutics
83%

Ahead Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 29, 2026
DebtDec 10, 2024
CrowdfundingApr 24, 2024
SeedJan 23, 2018

Key People

Founding team and executive leadership

Bruna Barneda Zahonero

Chief Operating Officer, Preclinical & clinical Development director

Executive Team

Ahead Therapeutics Investors

Notable investors and investment history

Ahead Therapeutics investors
InvestorRounds
JDRFGrant
Capital CellCrowdfunding
Spanish Government (Ministry of Science)Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 47% MoM.

  • Feb 1, 2026

    Grew 18% QoQ, from 17 to 20 employees.

Ahead Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ahead Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ahead Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range13
Year Founded2017
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?